БОРТЕЗОВІСТА
Analogs of БОРТЕЗОВІСТА
Find cheaper analogs and generic equivalents for БОРТЕЗОВІСТА.
Active Ingredient: Bortezomib
Product Overview
About БОРТЕЗОВІСТА
БОРТЕЗОВІСТА is a prescription medication containing the active ingredient Bortezomib, used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to a class of drugs known as proteasome inhibitors, which work by blocking the action of proteasomes, a type of enzyme that breaks down proteins in the body.
Key Benefits & Uses
- Treatment of multiple myeloma, a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow.
- Treatment of mantle cell lymphoma, a rare type of non-Hodgkin lymphoma.
- Induction of response in patients with multiple myeloma who have received at least two prior therapies.
Active Ingredient & Action
Bortezomib, the active ingredient in БОРТЕЗОВІСТА, works by binding to the 26S proteasome, a large protein complex responsible for degrading ubiquitinated proteins. By inhibiting the proteasome, Bortezomib disrupts the normal functioning of cells, leading to cell cycle arrest and apoptosis (cell death) in cancer cells.
Important Notes
БОРТЕЗОВІСТА should only be used under the guidance of a qualified healthcare professional. Common side effects include peripheral neuropathy, fatigue, and gastrointestinal symptoms. Patients with a history of hypersensitivity reactions to Bortezomib or other proteasome inhibitors should not receive БОРТЕЗОВІСТА. Regular monitoring of renal function and hematologic parameters is recommended during treatment.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.